Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Taltz for Laryngostenosis
Recruiting1 awardPhase 2
New Haven, Connecticut
This trial is testing if Taltz can help patients with idiopathic subglottic stenosis by reducing inflammation and scar tissue in their airways. This could decrease their need for repeated surgeries.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service